Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies-Reference-Cited by-同舟云学术

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies

Published:2023-02 Issue:2 Volume:4 Page:e58-e59
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Nadesalingam Angalee,Cantoni Diego,Aguinam Ernest T,Chan Andrew CY,Paloniemi Minna,Ohlendorf Luis,George Charlotte,Carnell George,Lyall Jon,Ferrari Matteo,Temperton Nigel,Wagner Ralf,Castillo-Olivares Javier,Baxendale Helen,Heeney Jonathan L

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference9 articles.

1. Higher vaccination rates predict reduction in SARS-CoV-2 transmission across the United States;Au;Infection,2022

2. Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK;Nadesalingam;Lancet Microbe,2021

3. Neutralisation hierarchy of SARS-CoV-2 variants of concern using standardised, quantitative neutralisation assays reveals a correlation with disease severity; towards deciphering protective antibody thresholds;Cantoni;medRxiv,2021

4. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection;Khoury;Nat Med,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model;Vaccines;2024-02-23

2. The Antiviral Activity of the Lectin Griffithsin against SARS-CoV-2 Is Enhanced by the Presence of Structural Proteins;Viruses;2023-12-18

3. A community study of neutralizing antibodies against SARS-CoV-2 in China;Frontiers in Immunology;2023-12-07

4. Airway and Systemic Immune Responses Following the Third COVID-19 Vaccination in COPD Patients;International Journal of Chronic Obstructive Pulmonary Disease;2023-12

5. Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period;Frontiers in Immunology;2023-10-20